glp 1 stdei Scam weight-loss drops marketed to Australians contain 'basically salty water', analysis finds | Scams GLP-1 Metabolic Health | The

The STEP trials (Semaglutide Treatment Effect in People with obesity) showed that weekly semaglutide injections produced average weight loss of 15.3 kg over 68 weeksapproximately 15% of body weight

McGough and colleagues found that over 40% of adults under 65 with private insurance could qualify for a GLP-1 drug under previous Food and Drug Administration (FDA) indications accounting for obesity and type 2 diabetes

Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography

AhmadiAbhari S, GuzmanCastillo M, Bandosz P, et al